Digital therapeutics,as an emerging effective and safe intervention driven by high-quality software programs,are increasingly being used in primary care based clinical practice.Cognitive-behavioral therapy(CBT)is the most wide-ly used classical approach in psychotherapy and is also a core technology in many digital therapeutics products.CBT in-terventions are usually limited by the lack of treatment space and professionals,which makes it impossible to reach out to a wider target group of patients.With the help of digital therapeutics,CBT technology can be integrated into the corre-sponding design module to break through these limitations.At present,CBT-digital therapeutics products are mainly used in the field of primary chronic disease prevention and treatment in the field of lifestyle intervention and patient-centered care,and there is still a large development potential for their application in health monitoring and prevention of common chronic diseases,disease treatment and optimization of drug treatment effects.As an important support to lead the effi-cient promotion of the quality of primary care services and meet the development of active health technology,CBT-digital therapeutics have ushered in key development opportunities driven by the strong support of the policy environment,the comprehensive technological innovation empowered by emerging technologies,and the increased willingness of patients with chronic diseases to manage their health.At the same time,there are still some key points that need to be broken through and improved in the future of CBT-digital therapeutics.In the future,it is necessary to pay attention to the accu-mulation of clinical data that meets the needs of supervision,and use algorithm technology to further accurately locate the personalized needs of patients based on patients'chronic disease data,so as to broaden the indications for chronic disease management of CBT-digital therapeutics.At the same time,it is necessary to further improve the regulatory regulations related to digital therapeutics,formulate an approval system suitable for digital therapeutics products,and improve indus-try standards in terms of data security,privacy protection,and medical insurance payment policies.
Cognitive-behavioral therapyDigital therapeuticsPrimary careChronic disease managementEvidence-based medicine
维普
万方数据
